Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Lifei Xiaoji Wan in Treatment of Advanced NSCLC [NA]

View source ↗

Summary

Clinical trial update for Lifei Xiaoji Wan in treating advanced non-small cell lung cancer; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lifei Xiaoji Wan (Lifei Xiaoji Wan)

Snippet

Sponsor: Henan University of Traditional Chinese Medicine | Conditions: Advanced Non Small Cell Lung Cancer | NA | Status: RECRUITING